BRIEF published on 03/19/2024 at 19:51, 2 years ago Eckert & Ziegler Announces Dividend Cut to Fund Future Investments Investment Eckert & Ziegler Financial Forecast Dividend Reduction Radiopharmaceuticals
BRIEF published on 03/19/2024 at 19:51, 2 years ago Eckert & Ziegler annonce une réduction de ses dividendes pour financer ses investissements futurs Investissement Eckert & Ziegler Prévisions Financières Réduction Des Dividendes Produits Radiopharmaceutiques
PRESS RELEASE published on 03/19/2024 at 19:46, 2 years ago EQS-Adhoc: Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024. Eckert & Ziegler reduces dividend to fund future investments, aiming for earnings growth in 2024. Details on financial performance and strategic moves disclosed Financial Performance Eckert & Ziegler Earnings Growth Dividend Reduction Strategic Investments
BRIEF published on 03/19/2024 at 10:58, 2 years ago Eckert & Ziegler Transitions to Societas Europaea Corporate Governance Shareholder Rights Eckert & Ziegler SE Societas Europaea Legal Transition
BRIEF published on 03/19/2024 at 10:58, 2 years ago Eckert & Ziegler rejoint Societas Europaea Société Européenne Gouvernance D'Entreprise Droits Des Actionnaires Eckert & Ziegler SE Transition Juridique
PRESS RELEASE published on 03/19/2024 at 10:53, 2 years ago Eckert & Ziegler Completes Change of Legal Form to SE Eckert & Ziegler completes change of legal form to SE, maintaining shareholder equity and operations. The company is a leading specialist in nuclear medicine and radiation therapy Eckert & Ziegler Legal Form SE Nuclear Medicine Radiation Therapy
BRIEF published on 02/28/2024 at 10:00, 2 years ago Eckert & Ziegler Étend Ses Activités sur le Ga-68 au Japon en Collaboration avec Novartis Eckert & Ziegler Imagerie Médicale Diagnostic Gallium-68 Novartis Pharma K.K.
BRIEF published on 02/28/2024 at 10:00, 2 years ago Eckert & Ziegler Expands Ga-68 Activities in Japan in Collaboration with Novartis Eckert & Ziegler Medical Imaging Diagnostic Gallium-68 Novartis Pharma KK
PRESS RELEASE published on 02/28/2024 at 10:00, 2 years ago Eckert & Ziegler Extends Ga-68 Activities in Japan Eckert & Ziegler extends Ga-68 activities in Japan in alliance with Novartis Pharma K.K. Clinical trial with GalliaPharm generator for Ga-68. Collaboration to enhance cancer therapies and diagnostics in Japan Eckert & Ziegler Clinical Trial Japan Ga-68 Radiopharmaceutical Industry
PRESS RELEASE published on 01/31/2024 at 14:00, 2 years 1 month ago Eckert & Ziegler to Supply Nucleus Radiopharma with Therapeutic Radioisotopes Ac-225 and Lu-177 Eckert & Ziegler to supply Nucleus Radiopharma with therapeutic radioisotopes Ac-225 and Lu-177 for cancer care, enabling advancement in radiotherapies and clinical development Cancer Care Eckert & Ziegler Nucleus Radiopharma Therapeutic Radioisotopes Radiotherapies
Published on 03/23/2026 at 13:05, 23 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 56 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 58 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 12:30, 58 minutes ago High Tide Resources Announces Closing of Concurrent Non-Brokered Private Placements for Gross Proceeds of $8.3 Million
Published on 03/23/2026 at 12:20, 1 hour 8 minutes ago Guanajuato Silver Adds Veteran Mine Operator to Board of Directors
Published on 03/23/2026 at 12:40, 48 minutes ago EQS-Adhoc: Ströer plans a dividend of €1.85 for fiscal year 2025 and approves a share buyback program of up to €50 million
Published on 03/23/2026 at 08:10, 5 hours 18 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 18 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 18 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 19 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 19 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
